US OKs 1st drug aimed at women with inherited breast cancer

U.S. regulators have approved the first drug aimed at women with advanced breast cancers caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC’s Lynparza (lihn-PAHR’zah) for patients with inherited BRCA gene mutations who have undergone chemotherapy. It’s the first in a fairly new class of medicines for ovarian cancer […] ...
3 Published By - The Seattle Times - 2018.01.12. 19:36
Share |